- hyperactivity / MGI
- impaired coordination / MGI
- abnormal dopamine level / MGI
- abnormal pain threshold / MGI
- abnormal noradrenaline level / MGI
- impaired conditioned place preference behavior / MGI
- impaired behavioral response to addictive substance / MGI
- impaired behavioral response to morphine / MGI
- abnormal nervous system physiology / MGI
- abnormal thermosensation / MGI
- decreased inflammatory response / MGI
- increased airway responsiveness / MGI
- abnormal touch/ nociception / MGI
- abnormal respiratory mucosa goblet cell morphology / MGI
- abnormal chemical nociception / MGI
- joint inflammation / MGI
- decreased nerve fiber response intensity / MGI
- hyperalgesia / MGI
- abnormal pulmonary respiratory rate / MGI
- decreased aggression / MGI
B6.129P2-Tacr1tm1Sph/H
Status | Available to order |
EMMA ID | EM:05452 |
Citation information | RRID:IMSR_EM:05452 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | B6.129P2-Tacr1tm1Sph/H |
Alternative name | NK1 Receptor knock-out / Backcrossed on C57BL/6 |
Strain type | Targeted Mutant Strains : Knock-out |
Allele/Transgene symbol | Tacr1tm1Sph |
Gene/Transgene symbol | Tacr1 |
Information from provider
Provider | S P Hunt |
Provider affiliation | Windeyer Institute of Medical Sciences, University College London |
Genetic information | Targeting construct for NK1 (or Tacr1) receptor is derived from 129/Sv DNA. A reporter/selection cassette (IRES-Gal-MC1-Neo) was inserted into exon 1 of the targeted allele, rendering the mRNA out-of-frame and thus no functional NK1 receptor can be produced. |
Phenotypic information | Deletion of Tacr1/NK1 receptor gene. Viable, normal breeding pattern. No obvious phenotype. |
Breeding history | Backcrossed for more than 10 generations. |
References |
|
Homozygous fertile | yes |
Homozygous viable | yes |
Homozygous matings required | no |
Immunocompromised | no |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Animals used for archiving | heterozygous C57BL/6 males |
Breeding at archiving centre | Males were archived upon arrival at the archiving centre. No breeding was carried out. |
Disease and phenotype information
MGI allele-associated human disease models
MGI phenotypes (allele matching)
MGI phenotypes (gene matching)
- decreased anxiety-related response / MGI
- hyperactivity / MGI
- impaired coordination / MGI
- abnormal body temperature homeostasis / MGI
- abnormal humoral immune response / MGI
- decreased inflammatory response / MGI
- abnormal dopamine level / MGI
- increased airway responsiveness / MGI
- abnormal touch/ nociception / MGI
- abnormal pain threshold / MGI
- abnormal nervous system electrophysiology / MGI
- abnormal respiratory mucosa goblet cell morphology / MGI
- abnormal mast cell physiology / MGI
- decreased circulating corticosterone level / MGI
- abnormal chemical nociception / MGI
- abnormal nociception after inflammation / MGI
- joint inflammation / MGI
- decreased vascular permeability / MGI
- decreased nerve fiber response intensity / MGI
- abnormal nervous system physiology / MGI
- abnormal thermosensation / MGI
- abnormal noradrenaline level / MGI
- abnormal neuron physiology / MGI
- hyperalgesia / MGI
- hyporesponsive to tactile stimuli / MGI
- decreased aggression / MGI
- increased chemical nociceptive threshold / MGI
- abnormal physiological response to xenobiotic / MGI
- impaired conditioned place preference behavior / MGI
- impaired behavioral response to xenobiotic / MGI
- impaired behavioral response to addictive substance / MGI
- impaired behavioral response to morphine / MGI
- decreased vocalization / MGI
- abnormal pulmonary respiratory rate response / MGI
Literature references
- Altered nociception, analgesia and aggression in mice lacking the receptor for substance P.;De Felipe C, Herrero J F, O'Brien J A, Palmer J A, Doyle C A, Smith A J, Laird J M, Belmonte C, Cervero F, Hunt S P, ;1998;Nature;392;394-7; 9537323
- Genetic background influences the behavioural and molecular consequences of neurokinin-1 receptor knockout.;McCutcheon J E, Fisher A S, Guzdar E, Wood S A, Lightman S L, Hunt S P, ;2008;The European journal of neuroscience;27;683-90; 18279320
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).